| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/13/2012 | CN102491972A Carbazole derivative, preparation method thereof, and application of carbazole derivative serving as anticancer drug |
| 06/13/2012 | CN102491963A Compound I and II, their application and preparation method in preparing medicines for preventing formation of melanins |
| 06/13/2012 | CN102491935A Nitrobenzaldehyde indole schiff base, preparation method and application thereof |
| 06/13/2012 | CN102491934A Hydroxyl and alkoxyl benzaldehyde indole Schiff bases, preparation method thereof, and application thereof |
| 06/13/2012 | CN102491933A Substituted 5-acrylic acid indole dione derivative, as well as preparation method and application thereof |
| 06/13/2012 | CN102491932A 3-indoline ketone derivative, and preparation method and application thereof |
| 06/13/2012 | CN102491931A 3-substituted indolone derivative and preparation method and application thereof |
| 06/13/2012 | CN102491897A Shikonin derivative containing fluorine carboxylic acid ester and synthetic method and application thereof |
| 06/13/2012 | CN102488970A Electromagnetic therapeutic apparatus and matched physical therapy liquid thereof |
| 06/13/2012 | CN102488910A Application of radioisotope-marked sunshine anthrone compound in preparing anti-tumor medicine |
| 06/13/2012 | CN102488909A Application of therapeutic isotope labeled Evans blue and its derivatives in preparing tumor targeted radiotherapy medicaments |
| 06/13/2012 | CN102488907A Nanometer gamma-ferric oxide/ polyaniline- chlorambucil and preparation method |
| 06/13/2012 | CN102488906A Superparamagnetic electric conductive gamma-iron oxide/polyaniline-lonidamine (gamma-Fe2O3/PAn-Lon) and preparation method thereof |
| 06/13/2012 | CN102488905A Electric and magnetic conductive gamma-iron oxide/polyaniline-mesna nanoparticles and preparation method thereof |
| 06/13/2012 | CN102488903A Application of miR-224 to preparation of medicament for treating non-small cell lung cancer |
| 06/13/2012 | CN102488896A Preparation method for anti-tumor medicine and adjuvant thereof |
| 06/13/2012 | CN102488891A Anti-tumor biological product and preparation method thereof |
| 06/13/2012 | CN102488890A Application of integrin blocker polypeptide AP25 in preparation of medicines for treating tumor |
| 06/13/2012 | CN102488868A Tumor-treating pills |
| 06/13/2012 | CN102488866A Anti-tumor Chinese medicinal composition Qinggong Xiaoliu Wan |
| 06/13/2012 | CN102488863A Chinese herbal medicine compound with anticancer effect, preparation method and detection method thereof |
| 06/13/2012 | CN102488839A Extraction method for saponins of rhizoma polygonati |
| 06/13/2012 | CN102488836A Medicine for treating bladder tumor |
| 06/13/2012 | CN102488809A Traditional Chinese medicine used for treating liver cancer, and preparation method thereof |
| 06/13/2012 | CN102488733A Processing method promoting conversion of ginseng and American ginseng saponins |
| 06/13/2012 | CN102488719A Method for improving triterpene output of Ganoderma lucidum liquid fermented mycelia |
| 06/13/2012 | CN102488713A Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution |
| 06/13/2012 | CN102488707A Preparation method and new application of polyinosinic preparation |
| 06/13/2012 | CN102488704A Preparation method of refined poly zic and application |
| 06/13/2012 | CN102488703A Method for preparing polyinosinic preparation and application of polyinosinic preparation to tumor resistance |
| 06/13/2012 | CN102488682A New application of chlorogenic acid in cancer resisting |
| 06/13/2012 | CN102488677A Application of thelephora ganbajun in preparation of antitumor drugs |
| 06/13/2012 | CN102488661A Method for preparing freeze-dried preparation of combretastatin A4 disodium phosphate |
| 06/13/2012 | CN102488658A Folacin-carboxymethyl chitosan modified pH sensitive taxol nanoliposome |
| 06/13/2012 | CN102488655A N3-ortho toluene formoxyl uracil nanosuspension and lyophilized preparation thereof |
| 06/13/2012 | CN102488210A Genistein hydrogel compound and its preparation method |
| 06/13/2012 | CN102068641B Chinese medicinal capsules for treating gynecological diseases |
| 06/13/2012 | CN102058744B Chinese medicinal composition for treating malignant tumor and preparation method thereof |
| 06/13/2012 | CN102038843B Syrup for treating gastric ulcer and lymphoma and preparation method thereof |
| 06/13/2012 | CN102028678B Application of salvianolic acid A in preparing anti-tumor metastasis medicine |
| 06/13/2012 | CN101984967B Manganoporphyrin-dichloroacetic acid combined medicament for treating Lung cancer |
| 06/13/2012 | CN101962651B L-methionine gamma-lyase gene from deep sea metagenome and expression product thereof |
| 06/13/2012 | CN101947232B Use of cactus pear fruit polysaccharides in preparation of medicaments or health-care products |
| 06/13/2012 | CN101914095B 2-chloropyridine derivative, preparation method and application thereof to preparation of medicines resistant to liver cancer |
| 06/13/2012 | CN101909602B Oral powder and granular antitumor agent |
| 06/13/2012 | CN101874779B Fructose diphosphate sodium liposome solid preparation and novel application thereof |
| 06/13/2012 | CN101732721B Biocompatibility nanoparticle and application thereof as drug conveying carrier |
| 06/13/2012 | CN101701018B 2-(4-aminoquinazoline) benzo [d] thiazole derivative and application thereof |
| 06/13/2012 | CN101683350B Preparation method and application of galloyl glucose compounds |
| 06/13/2012 | CN101679395B Triazolyl aminopyrimidine compounds |
| 06/13/2012 | CN101654679B Anti-tumor fusion gene and expression protein and application thereof |
| 06/13/2012 | CN101648011B Tumor targeting recombinant DNA vaccine, preparation method thereof and application thereof |
| 06/13/2012 | CN101641117B Pharmaceutical composition |
| 06/13/2012 | CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof |
| 06/13/2012 | CN101569619B New use of glyoxal bis (thiosemicarbazone) compound |
| 06/13/2012 | CN101460466B Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| 06/13/2012 | CN101356172B Kinase inhibitors |
| 06/13/2012 | CN101297667B Dandelion health-care tea and preparing process thereof |
| 06/13/2012 | CN101220068B A set of geldanamycin derivant and method for preparing the same |
| 06/13/2012 | CN101215303B Xylosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 06/13/2012 | CN101193682B Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an antiparasitic agent, and an active agent selected among carveol, thymol, eugenol, borneol and carvacrol |
| 06/13/2012 | CN101167760B Mushroom fermentation oral liquid with anti-tumor activity and preparation method |
| 06/13/2012 | CN101167759B Mushroom fermentation dry powder preparation with anti-tumor activity and preparation method |
| 06/13/2012 | CN101065144B Methods and compositions for treatment of hematologic cancers |
| 06/12/2012 | USRE43472 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 06/12/2012 | US8198448 Fused heterocyclic derivatives and methods of use |
| 06/12/2012 | US8198435 Crystal form of N-benzoyl-staurosporine |
| 06/12/2012 | US8198428 Identification of novel genes coding for small temporal RNAS |
| 06/12/2012 | US8198333 Cytostatic drug composition |
| 06/12/2012 | US8198323 Curcumin analogues and uses thereof |
| 06/12/2012 | US8198292 Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof |
| 06/12/2012 | US8198285 Pyrazine derivatives |
| 06/12/2012 | US8198273 Compounds and methods for kinase modulation, and indications therefor |
| 06/12/2012 | US8197839 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine |
| 06/12/2012 | US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 06/12/2012 | US8197813 Human antibodies that bind human TNFα |
| 06/12/2012 | US8197807 Nucleotide sequences coding muscle specific integrin binding protein for use as tool in targeting cancer cells for destruction |
| 06/12/2012 | CA2681962C Methods of administering epothilone analogs for the treatment of cancer |
| 06/12/2012 | CA2663965C Pyrazolopyrimidine derivative and use thereof as an anticancer agent |
| 06/12/2012 | CA2595514C Kinase inhibitors |
| 06/12/2012 | CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 06/12/2012 | CA2408323C Drug delivery systems for photodynamic therapy |
| 06/12/2012 | CA2404325C Immunotherapeutic methods and compositions |
| 06/12/2012 | CA2288992C Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 06/12/2012 | CA2262756C A tumor necrosis factor related ligand |
| 06/12/2012 | CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 06/07/2012 | WO2012075500A2 7-deazapurine modulators of histone methyltransferase, and methods of use thereof |
| 06/07/2012 | WO2012075492A2 Carbocycle-substituted purine and 7-deazapurine compounds |
| 06/07/2012 | WO2012075484A2 Novel drug targets to overcome de novo drug-resistance in multiple myeloma |
| 06/07/2012 | WO2012075414A2 Aptamer bioconjugate drug delivery device |
| 06/07/2012 | WO2012075396A2 Prodrugs of 6-cyclohexyl-1-hydroxy-4- methylpyridin-2(1h)-one and derivatives thereof |
| 06/07/2012 | WO2012075383A2 Bromodomain inhibitors and uses thereof |
| 06/07/2012 | WO2012075381A1 Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes |
| 06/07/2012 | WO2012075362A2 Chemokine cxcr4 receptor modulators and used related thereto |
| 06/07/2012 | WO2012075342A2 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody |
| 06/07/2012 | WO2012075340A2 Anti-ngf compositions and use thereof |
| 06/07/2012 | WO2012075324A1 Methods for treating a tumor using an antibody that specifically binds hmw-maa |
| 06/07/2012 | WO2012075275A2 Novel topical composition of sarracenia purpurea (pitcher plant) |
| 06/07/2012 | WO2012075253A2 Pharmaceutical compositions |
| 06/07/2012 | WO2012075241A2 Protease degradable polypeptides and uses thereof |